📇 Rhumatologue ·
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Praticien-chercheur
12 articles scientifiques publiés — formation continue solide
Référence presse grand public
Cité 4 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 ladepeche.fr · 03/03/2022
<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxORDBXWi1Fc19wM2kzQmVvak4wa3ByRVhaalpXcGtNbm1hODhITlZucXp6OUgxQXAtWWhnR3Z1Mms3RjhxeWtORURPWTB2aU1qSTRRdmotbzZNSEdLTVV4Mi0wTWVtaVlWclYtSXJhckZTRDNnSWRjdnQ3Z2NFSTI4UXdmREZlY09MV3c?oc=5" target="_blank">Nogaro. Installation d’un deuxième médec
📰 Le journal du Gers · 28/02/2022
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQbnZhRWhJLTdIRjJZdkZxQjFTYVdvZEdvRkhVOWlTclJORm1pSEJMa2YyUk1LVlBpNlMzWUJqYTF5TmdzS3VFQzQ2UllOYmdVMzFFRkpyS1lpd3VNbW9Ub1U0anVBaFRQd3FKa05MUXhjNjlnS181NVkwRDU4OTN1MUdieG55cG9rTk1JWU5JN0JlMm9yQUFMSFFXeTctN0laRURzSUFhM1dQaDQ?oc=5" target="_bla
📰 ladepeche.fr · 07/10/2021
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPR0lodXRUaHFoNWdBb2dsejZ0MUU5Wlp4R3pZeThaeVZrT09WNDhpTFc4OUUzMHhybnNxV0JkNlBHOFA3UkJ4bk5DdS11X3kxTGJJcVZNdmJfbXRJbVd5cDc1YU04WTFUME95ZWFDWXY1bnp2VkpzbDFocldoV3ZyT0EwRU01VkNsWHA0d0VQT1Eyb21rLVE?oc=5" target="_blank">Un nouveau médecin s’ins
📰 Sud Ouest · 21/10/2020
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQejRfRWlwS3ZneHQzNkZoQS1fdm8wZmdLQ2FYVndIMTg1Mm1VcGprdjRxdzNDRHA3aGRxTktEaldibWZ2U1g0eWRVVXd2UnZpME9LTjluQkJpU0NVZVJ4Tkd3U21HSExTZ3RoQVkwMkxPLUV5cE9SUW1RcWh2SE1zV3RLVkU1em5pM2NwUGtzSDdCY2VZYlZ1WWJmMA?oc=5" target="_blank">La santé, priorit
Nature genetics · 2009
American journal of human genetics · 2007
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
Abstract Background Enterococcus faecalis infective endocarditis (EFIE) is characterized by a higher frequency of relapses than other infective endocarditis. The role of the treatment on its occurrence remains poorly understood. The aim of this study was to investigate whether the antibiotic regimen could impact the risk of relapse in EFIE. Materials This was a multicenter retrospective study of patients diagnosed with definite EFIE between 2015 and 2019 in 14 French hospitals. The primary endpoint was the occurrence of relapses within the year following endocarditis diagnosis. As death was a competing risk for relapse, Fine and Gray models were used for studying risk factors and impact of treatment. Results Of the 279 patients included, 83 (29.7%) received the amoxicillin-gentamicin (A-G) combination, 114 (40.9%) amoxicillin-ceftriaxone (A-C), 63 (22.6%) A-G and A-C (A-G/A-C) sequentially, 9 (3.2%) amoxicillin (A), and 10 received other treatments. One-year-relapse rate was 9.3% (26 patients). Relapse occurred after a median delay of 107 days from EFIE diagnosis; 6 occurred after 6 months, and 6 were diagnosed by blood cultures in asymptomatic patients. In multivariate analysis, surgery during treatment was a protective factor against one-year relapse and death. The cumulative incidence of relapse 1 year after endocarditis was 46.2% for patients treated with amoxicillin, 13.4% with A-G, 14.7% with A-C, and 4.3% with A-G/A-C (P≥.05 in multivariate analysis). Conclusions Relapses after treatment of EFIE are frequent, frequently asymptomatic, and may occur more than 6 months after the initial episode.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Multicenter Study
Danneels P, Hamel JF, Picard L, Rezig S, et al.
European journal of haematology · 2021 · Clinical Trial, Phase III
Bouvier A, Hamel JF, Delaunay J, Delabesse E, et al.
Journal de gynecologie, obstetrique et biologie de la reproduction · 2014 · Journal Article
Muller F, Dreux S, Czerkiewicz I, Bernard M, et al.
Nature genetics · 2009 · Journal Article
Rice GI, Bond J, Asipu A, Brunette RL, et al.
American journal of human genetics · 2007 · Journal Article
de Brouwer AP, Williams KL, Duley JA, van Kuilenburg AB, et al.
Clinical biomechanics (Bristol, Avon) · 2022 · Journal Article
Desgagnés A, Patricio P, Bérubé N, Bernard S, et al.
Journal of cancer survivorship : research and practice · 2016 · Journal Article
Bernard S, Ouellet MP, Moffet H, Roy JS, et al.
Clinical biomechanics (Bristol, Avon) · 2022 · Journal Article
Desgagnés A, Patricio P, Bérubé N, Bernard S, et al.
Journal of cancer survivorship : research and practice · 2016 · Journal Article
Bernard S, Ouellet MP, Moffet H, Roy JS, et al.
European journal of pediatrics · 2004 · Case Reports
Faber MR, Verlaak R, Fiselier TJ, Hamel BC, et al.
Surgical and radiologic anatomy : SRA · 2001 · Case Reports
Bernard P, Le Borgne J, Dupas B, Kohnen-Shari N, et al.
Nephrologie & therapeutique · 2018 · Journal Article
Le Guillou A, Pladys A, Kihal W, Siebert M, et al.
Blood cancer journal · 2017 · Clinical Trial, Phase II
Hunault-Berger M, Maillard N, Himberlin C, Recher C, et al.
Blood cancer journal · 2017 · Clinical Trial, Phase II
Hunault-Berger M, Maillard N, Himberlin C, Recher C, et al.
Physiotherapy · 2021 · Journal Article
Bernard S, Gentilcore-Saulnier E, Massé-Alarie H, Moffet H
Surgical and radiologic anatomy : SRA · 2001 · Case Reports
Bernard P, Le Borgne J, Dupas B, Kohnen-Shari N, et al.